J 2015

MEK and TGF-beta Inhibition Promotes Reprogramming without the Use of Transcription Factor

VRBSKÝ, Jan, Tamás TEREH, Sergiy KYRYLENKO, Petr DVOŘÁK, Lumír KREJČÍ et. al.

Basic information

Original name

MEK and TGF-beta Inhibition Promotes Reprogramming without the Use of Transcription Factor

Authors

VRBSKÝ, Jan (203 Czech Republic, belonging to the institution), Tamás TEREH (348 Hungary, belonging to the institution), Sergiy KYRYLENKO (246 Finland, belonging to the institution), Petr DVOŘÁK (203 Czech Republic, belonging to the institution) and Lumír KREJČÍ (203 Czech Republic, guarantor, belonging to the institution)

Edition

Plos one, San Francisco, Public Library of Science, 2015, 1932-6203

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

Genetics and molecular biology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 3.057

RIV identification code

RIV/00216224:14110/15:00080987

Organization unit

Faculty of Medicine

UT WoS

000355700700073

Keywords in English

PLURIPOTENT STEM-CELLS; HUMAN SOMATIC-CELLS; SMALL-MOLECULE COMPOUNDS; PRIMORDIAL GERM-CELLS; SELF-RENEWAL; NEURONAL DIFFERENTIATION; PROGENITOR CELLS; MOUSE; INDUCTION; NANOG

Tags

Tags

International impact, Reviewed
Změněno: 31/8/2015 16:30, Ing. Mgr. Věra Pospíšilíková

Abstract

V originále

The possibility of replacing the originally discovered and widely used DNA reprogramming transcription factors is stimulating enormous effort to identify more effective compounds that would not alter the genetic information. Here, we describe the generation of induced pluripotent stem cells (iPSc) from head-derived primary culture of mouse embryonic cells using small chemical inhibitors of the MEK and TGF-beta pathways without delivery of exogenous transcription factors. These iPSc express standard pluripotency markers and retain their potential to differentiate into cells of all germ layers. Our data indicate that head-derived embryonic neural cells might have the reprogramming potential while neither the same primary cells cultivated over five passages in vitro nor a cell population derived from adult brain possesses this capacity. Our results reveal the potential for small molecules to functionally replace routinely used transcription factors and lift the veil on molecular regulation controlling pluripotency. The conditions described here could provide a platform upon which other genome non integrative and safer reprogramming processes could be developed. This work also shows novel potential for developing embryonic neural cells.

Links

EE2.3.20.0011, research and development project
Name: Centrum výzkumu pluripotentních buněk a nestability genomu
GAP207/12/2323, research and development project
Name: Endonuleazová a translokázová aktivita v restričních-modifikáčních komplexéch typu I
Investor: Czech Science Foundation
GA13-26629S, research and development project
Name: SUMO a stability genomu
Investor: Czech Science Foundation
NS10231, research and development project
Name: Neurální diferenciace u microRNA indukovaných pluripotentních kmenových buněk
Investor: Ministry of Health of the CR
SIGA549, interní kód MU
Name: METASTEM - Metabolická signalizace a energetická homeostáze u lidských embryonálních kmenových buněk (Acronym: METASTEM)
Investor: South-Moravian Region, Incoming grants